Alexander Heifetz
59 works · 1,936 citations · h-index 22
Top works
- An Integrated in Silico 3D Model-Driven Discovery of a Novel, Potent, and Selective Amidosulfonamide 5-HT1A Agonist (PRX-00023) for the Treatment of Anxiety and Depression
- Accurate calculation of the absolute free energy of binding for drug molecules
- G protein-coupled receptors: In silico drug discovery in 3D
- PREDICT modeling and in‐silico screening for G‐protein coupled receptors
- Predictions of Ligand Selectivity from Absolute Binding Free Energy Calculations
- The Fragment Molecular Orbital Method Reveals New Insight into the Chemical Nature of GPCR–Ligand Interactions
- Fighting COVID-19 with Artificial Intelligence
- Fragment Molecular Orbital Method Applied to Lead Optimization of Novel Interleukin-2 Inducible T-Cell Kinase (ITK) Inhibitors
- Toward an Understanding of Agonist Binding to Human Orexin-1 and Orexin-2 Receptors with G-Protein-Coupled Receptor Modeling and Site-Directed Mutagenesis
- The longevity gene INDY ( I 'm N ot D ead Y et) in metabolic control: Potential as pharmacological target
- Rapid and accurate assessment of GPCR–ligand interactions Using the fragment molecular orbital‐based density‐functional tight‐binding method
- GPCR structure, function, drug discovery and crystallography: report from Academia-Industry International Conference (UK Royal Society) Chicheley Hall, 1–2 September 2014
- Multiparameter Optimization in CNS Drug Discovery: Design of Pyrimido[4,5- d ]azepines as Potent 5-Hydroxytryptamine 2C (5-HT 2C ) Receptor Agonists with Exquisite Functional Selectivity over 5-HT 2A and 5-HT 2B Receptors
- Ensemble-Based Steered Molecular Dynamics Predicts Relative Residence Time of A2A Receptor Binders
- Novel 6,7,8,9-tetrahydro-5H-1,4,7,10a-tetraaza-cyclohepta[f]indene analogues as potent and selective 5-HT2C agonists for the treatment of metabolic disorders
- Protein–protein docking: Progress in CAPRI rounds 6–12 using a combination of methods: The introduction of steered solvated molecular dynamics
- Study of Human Orexin-1 and -2 G-Protein-Coupled Receptors with Novel and Published Antagonists by Modeling, Molecular Dynamics Simulations, and Site-Directed Mutagenesis
- Using the fragment molecular orbital method to investigate agonist–orexin-2 receptor interactions
- Discovery of the First Selective, Nonpeptidic Orexin 2 Receptor Agonists
- High Performance Computing for Drug Discovery and Biomedicine